Early prostate cancer is largely characterized by the accumulation of single nucleotide variants (SNVs) in genes like forkhead box protein A1 (FOXA1) and ATM, along with deletion of tumor suppressor genes like NKX3-1 and retinoblastoma transcriptional corepressor 1 (RB1). This evidence concerns the gene FOXA1 and prostate cancer.